Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy

被引:43
作者
Buda, Alessandro [1 ]
Gasparri, Maria Luisa [2 ,3 ]
Puppo, Andrea [4 ]
Mereu, Liliana [5 ]
De Ponti, Elena [6 ]
Di Martino, Giampaolo [1 ]
Novelli, Antonia [4 ]
Tateo, Saverio [5 ]
Muller, Michael [2 ,3 ]
Landoni, Fabio [1 ]
Papadia, Andrea [2 ,3 ]
机构
[1] Univ Milano Bicocca, Dept Obstet & Gynecol, Gynecol Oncol Unit, ASST Monza,San Gerardo Hosp, Monza, Italy
[2] Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland
[3] Univ Bern, Bern, Switzerland
[4] Regina Montis Regalis Hosp, Dept Obstet & Gynecol, Mondovi, Italy
[5] Santa Chiara Reg Hosp, Dept Gynecol & Obstet, Trento, Italy
[6] Univ Milano Bicocca, Dept Med Phys, ASST Monza, San Gerardo Hosp, Monza, Italy
关键词
High-risk endometrial cancer; Nodal staging; Sentinel node mapping; Selective lymphadenectomy; MAPPING ALGORITHM; SURVIVAL; CARCINOMA; IMPACT;
D O I
10.1016/j.ygyno.2018.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to determine the impact of the sentinel lymph node mapping algorithm (SLN-A) on the staging in high-risk endometrial cancer (EC) compared to SLN plus selective lymphadenectomy (S-LND). Methods. We retrospectively analyzed the database from a multicenter collaboration that included women with high risk features who underwent primary surgical staging. Results. One-hundred and seventy-one women were identified (171), 66 in the SLN-A and 105 in the S-LND group, respectively. Pelvic LD was performed on 115 patients (67.2%) and aortic dissection was performed in 54/105 of the women in the S-LND group (51%). The 5-year comparison did not show a significant difference in the strategy adopted for nodal staging, regarding disease-free survival (DFS) [HR: 0.82; 95% CI 0.53-1.28; p = 0.390]. Conclusions. In this study focusing on women with EC in the HR groups, we did not find a difference in the 5 year DFS when comparing the SLN-A strategy with S-LND. The SLN strategy did not seem to compromise the prognosis of patients with a higher risk of recurrence. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 30 条
  • [1] Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer
    AlHilli, Mariam M.
    Mariani, Andrea
    Bakkum-Gamez, Jamie N.
    Dowdy, Sean C.
    Weaver, Amy L.
    Peethambaram, Preema P.
    Keeney, Gary L.
    Cliby, William A.
    Podratz, Karl C.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 485 - 493
  • [2] The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer
    Baiocchi, Glauco
    Mantoan, Henrique
    Kumagai, Lillian Yuri
    Goncalves, Bruna Tirapelli
    Badiglian-Filho, Levon
    de Oliveira Menezes, Ademir Narciso
    Faloppa, Carlos Chaves
    De Brot, Louise
    Balieiro Anastacio da Costa, Alexandre Andre
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (13) : 3981 - 3987
  • [3] The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes
    Barlin, Joyce N.
    Khoury-Collado, Fady
    Kim, Christine H.
    Leitao, Mario M., Jr.
    Chi, Dennis S.
    Sonoda, Yukio
    Alektiar, Kaled
    DeLair, Deborah F.
    Barakat, Richard R.
    Abu-Rustum, Nadeem R.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 531 - 535
  • [4] Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: Current evidence
    Bogani, Giorgio
    Dowdy, Sean C.
    Cliby, William A.
    Ghezzi, Fabio
    Rossetti, Diego
    Mariani, Andrea
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (02) : 301 - 311
  • [5] The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers
    Buda, Alessandro
    Di Martino, Giampaolo
    Restaino, Stefano
    De Ponti, Elena
    Monterossi, Giorgia
    Giuliani, Daniela
    Ercoli, Alfredo
    Dell'Orto, Federica
    Dinoi, Giorgia
    Grassi, Tommaso
    Scambia, Giovanni
    Fanfani, Francesco
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 147 (03) : 528 - 534
  • [6] Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection
    Buda, Alessandro
    Lissoni, Andrea
    Milani, Rodolfo
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (01)
  • [7] Pelvic lymphadenectomy in cervical cancer-surgical anatomy and proposal for a new classification system
    Cibula, D.
    Abu-Rustum, N. R.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (01) : 33 - 37
  • [8] ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
    Colombo, N.
    Creutzberg, C.
    Amant, F.
    Bosse, T.
    Gonzalez-Martin, A.
    Ledermann, J.
    Marth, C.
    Nout, R.
    Querleu, D.
    Mirza, M. R.
    Sessa, C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (01) : 16 - 41
  • [9] Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research
    Cormier, Beatrice
    Rozenholc, Alexandre T.
    Gotlie, Walter
    Plante, Marie
    Giede, Christopher
    [J]. GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 478 - 485
  • [10] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Carinelli, Silvestro
    Provencher, Diane
    Hanzen, Chantal
    Lutgens, Ludy C. H. W.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    D'Amico, Romerai
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    [J]. LANCET ONCOLOGY, 2018, 19 (03) : 295 - 309